Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018

August 14, 2018 — NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai...

Videos | Cath Lab | August 13, 2018

Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and...

News | Venous Therapies | August 08, 2018

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to...

Videos | Stents Bioresorbable | August 06, 2018

Patrick Serruys, M.D., Ph.D., Imperial College London, explains where development of bioresorbable scaffolds stands...

More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018

August 6, 2018 — A new test to assess a whether or not someone is having a...

Boston Scientific Closes Claret Medical Acquisition, Announces Positive Reimbursement Decision
News | Embolic Protection Devices | August 03, 2018

August 3, 2018 — Boston Scientific Corp. announced it has recently closed its...

CT-FFR example showing heavily calcified coronary arteries on CT that did not have hemodynamically significant impact on blood flow.

FFR-CT was by far the hottest cardiac technology topic on DAIC in July. Eight of the top 20 pieces of content were about or mention FFR-CT. This image shows an example of the image-based technology that noninvasively assesses coronary fractional flow reserve (FFR) for the entire coronary tree. The CT image on the left shows two heavily calcified coronary arteries, but the FFR-CT analysis shows there is not a significant impact on hemodynamics, so the patient does not need revascularization. 

Feature | August 02, 2018 | Dave Fornell, Editor

August 2, 2018 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC...

Transcarotid Artery Revascularization Shows Favorable Outcomes in Patients With Carotid Artery Disease
News | Stents Carotid | July 30, 2018

July 30, 2018 — Silk Road Medical Inc. recently announced the presentation of...

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system  is being tested in the SUMMIT Trial.

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system.

Feature | Heart Valve Technology | July 26, 2018

July 26, 2018 — The pivotal clinical study in the U.S. of the Abbott Tendyne...

iFR reference numbers posted for new users in the cath lab at Northwestern Medicine's Central DuPage Hospital in Winfield, Ill.
News | FFR Technologies | July 26, 2018

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert...

A comparison of CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockages and the correspending FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention.

A comparison of a CT image of heavily calcified coronary arteries that appear to present a significant hemodynamic blockage and the corresponding FFR-CT showing the patient had adequate blood flow and does not need a diagnostic angiogram or intervention. Image courtesy of Kavitha Chinnaiyan, William Beaumont Hospital.

Feature | CT Angiography (CTA) | July 23, 2018 | Dave Fornell, Editor

The use of non-invasive fractional flow reserve CT (FFR-CT) was the hottest topic discussed at the Society of...

Claret's FDA-cleared Sentinel Cerebral Embolic Protection System for TAVR will expand Boston Scientific's structural heart portfolio. It collects emboli knocked loose that would otherwise lodge in the brain and potentially cause a stroke.

Claret's FDA-cleared Sentinel Cerebral Embolic Protection System for TAVR will expand Boston Scientific's structural heart portfolio. It collects emboli knocked loose that would otherwise lodge in the brain and potentially cause a stroke. 

News | Embolic Protection Devices | July 20, 2018

July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has...

Videos | CT Angiography (CTA) | July 19, 2018

Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine...

First U.S. Patients Treated With Second-Generation Pantheris Atherectomy Device
News | Atherectomy Devices | July 18, 2018

July 18, 2018 — Avinger Inc. announced in June that several physicians have successfully treated over 40 patients...

Overlay Init